KAMADA LTD — Investor Relations & Filings
Filings indexed
444
across all filing types
Latest filing
2026-03-31
Foreign Filer Report
Country
US
United States of America
Listing
US
KMDA
Kamada Ltd. is a vertically integrated global biopharmaceutical company focused on specialty plasma-derived therapeutics. The company engages in the research, development, manufacturing, and commercialization of protein therapeutics derived from human plasma. It utilizes a proprietary platform technology for protein extraction and purification to address rare and serious conditions. Key therapeutic areas include Alpha-1 Antitrypsin Deficiency (AATD), with a development pipeline featuring an inhaled AAT therapy, and the prevention of Cytomegalovirus (CMV) disease in transplant recipients. The company's operations also encompass the collection of human plasma through its U.S.-based subsidiary.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - KAMADA LTD (0001567529) (Filer) | 2026-03-31 | English | |
| 6-K - KAMADA LTD (0001567529) (Filer) | 2026-03-26 | English | |
| 3 - KAMADA LTD (0001567529) (Issuer) | 2026-03-23 | English | |
| 3 - KAMADA LTD (0001567529) (Issuer) | 2026-03-17 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-07 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-18 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 33112606 | 6-K - KAMADA LTD (0001567529) (Filer) | 2026-03-31 | English | ||
| 33047153 | 6-K - KAMADA LTD (0001567529) (Filer) | 2026-03-26 | English | ||
| 33012723 | 3 - KAMADA LTD (0001567529) (Issuer) | 2026-03-23 | English | ||
| 32964739 | 3 - KAMADA LTD (0001567529) (Issuer) | 2026-03-17 | English | ||
| 12626224 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-07 | English | ||
|
2025
10 filings
| |||||
| 12626225 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-18 | English | ||
| 12626226 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-10 | English | ||
| 12626227 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-08 | English | ||
| 12626228 | AMENDMENT NO. 1 TO FORM 6-K | 2025-12-02 | English | ||
| 12626235 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-10 | English | ||
| 12626236 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-04 | English | ||
| 12626238 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-10-23 | English | ||
| 12626239 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-09-02 | English | ||
| 12626244 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-08-13 | English | ||
| 12626245 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-08-11 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
KAMADA LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33046/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33046 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33046 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33046 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33046}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for KAMADA LTD (id: 33046)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.